Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
J Ovarian Res. 2024 Apr 2;17(1):71. doi: 10.1186/s13048-024-01397-1.
J Ovarian Res. 2024.
PMID: 38566237
Free PMC article.
Ovarian cancer stem cells: What progress have we made?
Al-Alem LF, Pandya UM, Baker AT, Bellio C, Zarrella BD, Clark J, DiGloria CM, Rueda BR.
Al-Alem LF, et al. Among authors: zarrella bd.
Int J Biochem Cell Biol. 2019 Feb;107:92-103. doi: 10.1016/j.biocel.2018.12.010. Epub 2018 Dec 17.
Int J Biochem Cell Biol. 2019.
PMID: 30572025
Review.
Item in Clipboard
Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau.
Starbuck K, Al-Alem L, Eavarone DA, Hernandez SF, Bellio C, Prendergast JM, Stein J, Dransfield DT, Zarrella B, Growdon WB, Behrens J, Foster R, Rueda BR.
Starbuck K, et al. Among authors: zarrella b.
Oncotarget. 2018 May 1;9(33):23289-23305. doi: 10.18632/oncotarget.25289. eCollection 2018 May 1.
Oncotarget. 2018.
PMID: 29796189
Free PMC article.
Item in Clipboard
Cite
Cite